JP2010222379A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010222379A5 JP2010222379A5 JP2010150627A JP2010150627A JP2010222379A5 JP 2010222379 A5 JP2010222379 A5 JP 2010222379A5 JP 2010150627 A JP2010150627 A JP 2010150627A JP 2010150627 A JP2010150627 A JP 2010150627A JP 2010222379 A5 JP2010222379 A5 JP 2010222379A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- residues
- fetoprotein
- acid sequence
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US3837597P | 1997-02-13 | 1997-02-13 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006038626A Division JP2006188528A (ja) | 1997-02-13 | 2006-02-15 | 肝細胞癌の予防又は処置のための組成物 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2010222379A JP2010222379A (ja) | 2010-10-07 |
| JP2010222379A5 true JP2010222379A5 (https=) | 2010-11-18 |
Family
ID=21899585
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP53591698A Expired - Lifetime JP3816959B2 (ja) | 1997-02-13 | 1998-02-13 | 肝細胞癌の予防および処置 |
| JP2006038626A Withdrawn JP2006188528A (ja) | 1997-02-13 | 2006-02-15 | 肝細胞癌の予防又は処置のための組成物 |
| JP2010150627A Pending JP2010222379A (ja) | 1997-02-13 | 2010-06-30 | 肝細胞癌の予防又は処置のための組成物 |
Family Applications Before (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP53591698A Expired - Lifetime JP3816959B2 (ja) | 1997-02-13 | 1998-02-13 | 肝細胞癌の予防および処置 |
| JP2006038626A Withdrawn JP2006188528A (ja) | 1997-02-13 | 2006-02-15 | 肝細胞癌の予防又は処置のための組成物 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20020031520A1 (https=) |
| EP (1) | EP0979239B1 (https=) |
| JP (3) | JP3816959B2 (https=) |
| KR (1) | KR100460583B1 (https=) |
| CN (2) | CN1222536C (https=) |
| AU (1) | AU6435398A (https=) |
| DE (1) | DE69836209D1 (https=) |
| WO (1) | WO1998035981A1 (https=) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2001058922A2 (en) * | 2000-02-10 | 2001-08-16 | The Regents Of The University Of California | Method and compositions for treating hepatocellular cancer |
| FI118263B (fi) * | 2002-10-09 | 2007-09-14 | Timo Kalevi Korpela | Kaspaasiaktiivisuutta säätelevät peptidit |
| US8932829B2 (en) | 2005-07-07 | 2015-01-13 | Elena Dudich | Recombinant alpha-fetoprotein and compositions thereof |
| GB0617564D0 (en) * | 2006-09-06 | 2006-10-18 | Ucl Business Plc | Peptides and methods |
| KR100900742B1 (ko) * | 2007-05-17 | 2009-06-08 | 크레아젠 주식회사 | 인간 간암 동물모델 및 이를 이용한 수지상세포-유래 간암면역치료제의 예방 및 치료 효능을 분석하는 방법 |
| CA2778533A1 (en) * | 2009-10-22 | 2011-04-28 | Ricardo J. Moro | Peptides that bind the alpha-fetoprotein (afp) receptor and uses thereof |
| CA2894511C (en) | 2012-12-11 | 2021-12-07 | Albert Einstein College Of Medicine Of Yeshiva University | Methods for high throughput receptor:ligand identification |
| WO2016161390A1 (en) | 2015-04-03 | 2016-10-06 | Eureka Therapeutics, Inc. | Constructs targeting afp peptide/mhc complexes and uses thereof |
| CN105126074A (zh) * | 2015-09-30 | 2015-12-09 | 中国药科大学 | 多肽afp12在制备抗肿瘤药物中的应用 |
| CN105524884A (zh) * | 2016-02-29 | 2016-04-27 | 时宏珍 | Hla-a0201限制性抗afp抗原特异性ctl的制备方法 |
| CN109689096A (zh) | 2016-05-18 | 2019-04-26 | 阿尔伯特爱因斯坦医学院公司 | 变体pd-l1多肽、t细胞调节性多聚体多肽及其使用方法 |
| WO2017201210A1 (en) | 2016-05-18 | 2017-11-23 | Cue Biopharma, Inc. | T-cell modulatory multimeric polypeptides and methods of use thereof |
| ES2973548T3 (es) | 2016-12-22 | 2024-06-20 | Cue Biopharma Inc | Polipéptidos multiméricos moduladores de linfocitos T y métodos para su uso |
| EP3565829A4 (en) | 2017-01-09 | 2021-01-27 | Cue Biopharma, Inc. | T-CELL-MODULATING MULTIMERIC POLYPEPTIDES AND METHOD OF USING THEREOF |
| US20200010528A1 (en) | 2017-03-15 | 2020-01-09 | Cue Biopharma, Inc. | Methods for modulating an immune response |
| CN111886241A (zh) | 2018-01-09 | 2020-11-03 | 库尔生物制药有限公司 | 多聚体t细胞调节多肽及其使用方法 |
| WO2021231376A2 (en) | 2020-05-12 | 2021-11-18 | Cue Biopharma, Inc. | Multimeric t-cell modulatory polypeptides and methods of use thereof |
| WO2022056014A1 (en) | 2020-09-09 | 2022-03-17 | Cue Biopharma, Inc. | Mhc class ii t-cell modulatory multimeric polypeptides for treating type 1 diabetes mellitus (t1d) and methods of use thereof |
| CN113416729B (zh) * | 2021-05-18 | 2022-11-22 | 遵义医科大学附属医院 | 一种肝脏靶向调控甲胎蛋白基因的shRNA和cDNA及其应用 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH025866A (ja) * | 1988-06-27 | 1990-01-10 | Kansai Shin Gijutsu Kenkyusho:Kk | ヒトアルファフェトプロテインドメインｉ遺伝子、対応プラスミド組換体、対応形質転換体、該ドメインｉの製造法及び製造された該ドメインｉ |
| IT1226551B (it) * | 1988-07-29 | 1991-01-24 | Sclavo Spa | Peptide sintetico immunologicamente attivo capace di indurre la produzione di anticorpi con elevata specificita' verso l'alfa- fetoproteina e loro impiego in campo diagnostico |
| US5633234A (en) * | 1993-01-22 | 1997-05-27 | The Johns Hopkins University | Lysosomal targeting of immunogens |
| US5593972A (en) * | 1993-01-26 | 1997-01-14 | The Wistar Institute | Genetic immunization |
| EP0805687A4 (en) * | 1995-01-24 | 2000-05-31 | Robert A Murgita | ALPHA-F RECOMBINANT HUMAN TOPROTEIN AND USES THEREOF |
-
1998
- 1998-02-13 JP JP53591698A patent/JP3816959B2/ja not_active Expired - Lifetime
- 1998-02-13 AU AU64353/98A patent/AU6435398A/en not_active Abandoned
- 1998-02-13 DE DE69836209T patent/DE69836209D1/de not_active Expired - Lifetime
- 1998-02-13 CN CNB988052288A patent/CN1222536C/zh not_active Expired - Lifetime
- 1998-02-13 EP EP98910001A patent/EP0979239B1/en not_active Expired - Lifetime
- 1998-02-13 CN CNA2005100915162A patent/CN1739791A/zh active Pending
- 1998-02-13 WO PCT/US1998/002753 patent/WO1998035981A1/en not_active Ceased
- 1998-02-13 KR KR10-1999-7008375A patent/KR100460583B1/ko not_active Expired - Lifetime
-
1999
- 1999-08-12 US US09/373,913 patent/US20020031520A1/en not_active Abandoned
-
2006
- 2006-02-15 JP JP2006038626A patent/JP2006188528A/ja not_active Withdrawn
-
2010
- 2010-06-30 JP JP2010150627A patent/JP2010222379A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2010222379A5 (https=) | ||
| JP2015525217A5 (https=) | ||
| JP2014525439A5 (https=) | ||
| NZ593833A (en) | Extended recombinant polypeptides and compositions comprising same | |
| JP2013513377A5 (https=) | ||
| EP3919507A3 (en) | Novel peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers | |
| JP2024041747A5 (https=) | ||
| JP2009268467A5 (https=) | ||
| EP3712165A3 (en) | Novel peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers | |
| HRP20240135T1 (hr) | Fgf21 mutanti i njihove upotrebe | |
| RU2021134101A (ru) | Модифицированная j-цепь | |
| JP2011530309A5 (https=) | ||
| JP2014224126A5 (https=) | ||
| JP2015134796A5 (https=) | ||
| MX2020010806A (es) | Peptidos anti-inflamatorios y usos de los mismos. | |
| MX2021000030A (es) | Metodos y composiciones que utilizan polipeptidos variantes klotho. | |
| NZ707439A (en) | Modified factor ix polypeptides and uses thereof | |
| JP2015514395A5 (https=) | ||
| NZ705899A (en) | Inhibiting peptides derived from triggering receptor expressed on myeloid cells-1 (trem-1) trem-like transcript 1 (tlt-1) and uses thereof | |
| NZ726623A (en) | Improved peptide pharmaceuticals for insulin resistance | |
| CO6430475A2 (es) | Polipéptidos que tienen actividad de celulasa | |
| NZ609216A (en) | Anticancer fusion protein | |
| EP2589658A4 (en) | PARTIAL REGION POLYPEPTIDE OF REIC / DKK-3 PROTEIN | |
| JP2014519526A5 (https=) | ||
| NZ609916A (en) | Hla-binding peptides derived from prostate-associated antigenic molecules and methods of use thereof |